Propel Bio Management, LLC Portfolio Holdings

Propel Bio Management, LLC

$82.4 Billion
Q2 2025

Propel Bio Management, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $82.4 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Plains Gp Holdings LP with a value of $24.7B, Achieve Life Sciences Inc with a value of $13.9B, Akero Therapeutics, Inc. with a value of $12.2B, Phathom Pharmaceuticals, Inc. with a value of $8.85B, and Abeona Therapeutics Inc. with a value of $5.53B.

Examining the 13F form we can see an decrease of $3.68B in the current position value, from $86.1B to 82.4B.

Propel Bio Management, LLC is based out at Los Angeles, CA

Below you can find more details about Propel Bio Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $82.4 Billion

Healthcare: $42.9 Billion

Energy: $24.7 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PAGP Plains Gp Holdings LP Energy	$3.67B	$24.7 Billion 30.01% of portfolio	1,272,360	Q3 2024 Reduced 7.29%
AKRO Akero Therapeutics, Inc. Healthcare	$2.23B	$12.2 Billion 14.82% of portfolio	228,884	Q1 2025 Reduced 33.41%

Summary

Portfolio
No. of Stocks 16
Current Value $82.4 Billion
Prior Value $86.1 Billion
Filing
Period Q2 2025
Filing Date August 13, 2025
Form Type 13F-HR
Activity in Q2 2025
New Purchases 2 stocks
Additional Purchases 5 stocks
Sold out of 0 stocks
Reduced holdings in 2 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.

Account

Propel Bio Management, LLC Portfolio Holdings